Subscribe to MDT Magazine News

23andMe announces agreement with Pfizer to research inflammatory bowel disease

August 12, 2014 3:06 pm | by EurekAlert! | Comments

23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD.


R&D Magazine Announces Scientist and Innovator of the Year Award Winners

August 12, 2014 2:42 pm | by Lindsay Hock, Managing Editor, R&D Magazine | Comments

R&D Magazine today introduced its annual Scientist of the Year Award winner, Dr. Karl Deisseroth, and its Innovator of the Year Award winner, Dr. Hugh Herr. As R&D Magazine's 49th Scientist of the Year Award winner, Dr. Deisseroth is a leading researcher in the rapidly growing field of optogenetics, having invented ...

From eons to seconds, proteins exploit the same forces

August 12, 2014 2:36 pm | by Mike Williams, Rice University | Comments

Nature's artistic and engineering skills are evident in proteins, life's robust molecular machines. Scientists at Rice Univ. have now employed their unique theories to show how the interplay between evolution and physics developed these skills. A Rice team led by biophysicists ...


A highly sensitive microsphere-based assay for early detection of Type I diabetes

August 12, 2014 2:24 pm | by EurekAlert! | Comments

A team of researchers from the Center for Engineering in Medicine at the Massachusetts General Hospital have developed a novel fluorescence-based assay for sensitive detection of antibodies within microliter volume serum samples. This new assay is at least 50 times more sensitive than the traditional radioimmunoassay (RIA), which is the gold standard currently used in the clinic. This new technology is ...

Synthetic molecule makes cancer self-destruct

August 12, 2014 1:40 pm | by The University of Texas at Austin | Comments

Researchers from The University of Texas at Austin and five other institutions have created a molecule that can cause cancer cells to self-destruct by ferrying sodium and chloride ions into the cancer cells. These synthetic ion transporters, described this week...

Medical device company staffers admit to fraud

August 12, 2014 12:30 pm | by The Associated Press | Comments

Federal prosecutors say two staffers at a northern New Jersey medical devices firm have admitted their roles in a scheme to defraud hospitals out of more than $800,000. Daniel Metz, a 34-year-old Fairfield resident, and 35-year-old Charles Carey Jr., of Clark, both pleaded guilty Tuesday to...

Hijacking the Brain's Blood Supply: Tumor Discovery Could Aid Treatment

August 12, 2014 11:21 am | by University of Michigan Health System | Comments

Dangerous brain tumors hijack the brain's existing blood supply throughout their progression, by growing only within narrow potential spaces between and along the brain's thousands of small blood vessels, new research shows for the first time. The findings contradict the concept that brain tumors need to grow their own blood vessels to keep themselves growing ...


Expert Panel Concludes Neurostimulation Can Be Life-Changing Therapy for Chronic Pain

August 12, 2014 11:07 am | by Johns Hopkins Medicine | Comments

Chronic pain, which persists despite the fact that an injury has healed, can last for many months or years and may affect up to 15 percent of the adult population at any point in time. While it is a condition in its own right, it can be a component of other conditions. Neurostimulation, which involves stimulating pain-sensing nerves to convert painful sensations into nonpainful ones, offers ...


An easier way to manipulate malaria genes

August 12, 2014 10:59 am | by EurekAlert! | Comments

Plasmodium falciparum, the parasite that causes malaria, has proven notoriously resistant to scientists' efforts to study its genetics. It can take up to a year to determine the function of a single gene, which has slowed efforts to develop new, more targeted drugs and vaccines. MIT biological engineers have now demonstrated that


Robotic-assisted imaging: from trans-Atlantic evaluation to help in daily practice

August 12, 2014 10:42 am | by EurekAlert! | Comments

While in Germany, Partho P. Sengupta, MD, of Icahn School of Medicine at Mount Sinai used a computer to perform a robot-assisted trans-Atlantic ultrasound examination on a person in Boston. In another study Kurt Boman, MD, of Umeå University in Sweden in collaboration with Mount Sinai, showed how a cardiologist's video e-consultation, coupled with ...


Synthetic bones may help in search for shock wave defense

August 12, 2014 10:27 am | by U.S. Army | Comments

Shock waves from battlefield explosions are invisible threats for U.S. Soldiers and their top-of-the-line combat helmets, but with new studies in synthetic human physiology, researchers are learning how to lessen blast wave effects on the brain. Exactly how, and to what degree, these waves cause brain damage is ...

'Seeing' through virtual touch is believing

August 12, 2014 9:46 am | by EurekAlert! | Comments

'Seeing' through virtual touch is believing. A University of Cincinnati experiment aimed at this diverse and growing population could spark development of advanced tools to help all the aging baby boomers, injured veterans, diabetics and white-cane-wielding pedestrians navigate the blurred edges of everyday life.

Asbestos going strong in developing world, where industry glosses over scientific consensus

August 12, 2014 9:25 am | by Katy Daigle, The Associated Press | Comments

VAISHALI, India - The executives mingled over tea and sugar cookies, and the chatter was upbeat. Their industry, they said at the conference in the Indian capital, saves lives and brings roofs, walls and pipes to some of the world's poorest people. The industry's wonder product, though, is one...

BioTime Receives FDA Premarket Notification Clearance for Premvia 510(k)

August 12, 2014 9:25 am | by The Associated Press | Comments

ALAMEDA, Calif.--(BUSINESS WIRE)--Aug 12, 2014--BioTime, Inc. (NYSE MKT: BTX) today announced that it has received notice from the FDA’s Center for Devices and Radiologic Health that Premvia ™ has been cleared for marketing as a Class II medical device. Premvia ™ is the first FDA-cleared member...

Biocompatible Protective Coatings Widen Application Scope in Medical Devices, Finds Frost & Sullivan

August 12, 2014 8:29 am | by PR Newswire | Comments

MOUNTAIN VIEW, Calif., Aug. 12, 2014 /PRNewswire/ -- Innovations will surge in the protective coatings industry by 2020, giving rise to a range of improved biocompatible and durable coatings that enable implant devices for use in orthopedic, orthodontic and cardiac applications. The...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.